Mark Christopher, National Eye Institute (F);
Christopher Bowd, None;
James Proudfoot, None;
Nicole Brye, None;
Akram Belghith, None;
Michael Goldbaum, None;
Jasmin Rezapour, German Ophthalmological Society (DOG) (F), German Research Foundation (DFG) (F);
Massimo Fazio, EyeSight Foundation of Alabama (F), Heidelberg Engineering (F), National Eye Institute (F), Research to Prevent Blindness (F);
Christopher Girkin, EyeSight Foundation of Alabama (F), Heidelberg Engineering (F), National Eye Institute (F), Research to Prevent Blindness (F);
C Gustavo De Moraes, Belite (C), Carl Zeiss Meditec (C), Galimedix (C), Heidelberg Engineering (R), Novartis (C), Perfuse Therapeutics (C), Reichert (C), Topcon (R);
Jeffrey Liebmann, Alcon (C), Allergan (C), Bausch & Lomb (C), Bausch & Lomb (F), Carl Zeiss Meditec (C), Carl Zeiss Meditec (F), Heidelberg Engineering (C), Heidelberg Engineering (F), National Eye Institute (F), Novartis (F), Optovue (F), Reichert (C), Reichert (F), Research to Prevent Blindess (F), Valeant Pharmaceuticals (C);
Robert Weinreb, Aerie Pharmaceuticals (C), Allergan (C), Bausch & Lomb (C), Bausch & Lomb (F), Carl Zeiss Meditec (F), Carl Zeiss Meditec (P), Centervue (F), Equinox (C), Eyenovia (C), Heidelberg Engineering (F), Implantdata (C), Konan (F), National Eye Institute (F), Nicox (C), Optovue (F), Toromedes (P);
Linda Zangwill, Carl Zeiss Meditec (F), Carl Zeiss Meditec (P), Heidelberg Engineering (F), National Eye Institute (F), Optovue (F), Topcon (F)